Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-30

FDA Approved: FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE — Original Application (Aurohealth LLC)

View source ↗

Summary

FDA approved Aurohealth LLC’s original ANDA for a combination tablet containing fexofenadine hydrochloride and pseudoephedrine hydrochloride. This marks the app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexofenadine hydrochloride and pseudoephedrine hydrochloride (fexofenadine hydrochloride and pseudoephedrine hydrochloride)

Snippet

ORIG AP for FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE (FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE)